Could low eGFR indicate chronic kidney disease?

Low eGFR (estimated glomerular filtration rate) is a key indicator of chronic kidney disease, with values below 60 mL/min/1.73m² for three months or more suggesting kidney dysfunction. Regular monitoring through blood tests can help detect CKD early when interventions are most effective.

Questions on this topic?Ask Sai, our AI longevity expert.
Ask Sai

Understanding eGFR and Its Role in Kidney Health

Your kidneys work tirelessly to filter waste products from your blood, maintain fluid balance, and regulate essential minerals. When kidney function declines, one of the most reliable ways to detect it is through a blood test that measures your estimated glomerular filtration rate (eGFR). This simple calculation provides crucial insights into how well your kidneys are performing their vital filtering duties.

The eGFR test estimates how much blood your kidneys filter per minute, expressed in milliliters per minute per 1.73 square meters of body surface area (mL/min/1.73m²). Unlike direct kidney function measurements that require complex procedures, eGFR can be calculated from a routine blood test measuring creatinine levels, along with factors like age, sex, and race. This accessibility makes it an invaluable screening tool for detecting kidney problems before symptoms appear.

Understanding your eGFR is particularly important because chronic kidney disease (CKD) often develops silently over years. By the time symptoms emerge, significant kidney damage may have already occurred. Regular monitoring of your eGFR through comprehensive health testing can help identify kidney dysfunction early, when lifestyle changes and medical interventions can be most effective.

CKD Stages Based on eGFR Levels

CKD staging helps guide treatment intensity and monitoring frequency. Kidney damage refers to abnormalities like protein in urine or structural changes.
CKD StageeGFR Range (mL/min/1.73m²)Kidney FunctionTypical Management
Stage 1Stage 1≥90 with kidney damageNormal or highAddress underlying causes, monitor annually
Stage 2Stage 260-89 with kidney damageMildly decreasedControl risk factors, monitor annually
Stage 3aStage 3a45-59Mild to moderately decreasedActive treatment, monitor every 6 months
Stage 3bStage 3b30-44Moderately to severely decreasedSpecialist referral, monitor every 3 months
Stage 4Stage 415-29Severely decreasedPrepare for dialysis/transplant, monitor every 1-3 months
Stage 5Stage 5<15Kidney failureDialysis or transplant required

CKD staging helps guide treatment intensity and monitoring frequency. Kidney damage refers to abnormalities like protein in urine or structural changes.

What Is Considered a Low eGFR?

A normal eGFR typically falls above 90 mL/min/1.73m², though values between 60-89 may still be considered normal depending on your age and other factors. However, when eGFR drops below 60 mL/min/1.73m² and remains there for three months or more, it indicates chronic kidney disease. The lower the eGFR, the more severe the kidney dysfunction.

Healthcare providers use eGFR values to classify CKD into five stages, which helps guide treatment decisions and monitoring frequency. Understanding these stages can help you grasp the significance of your test results and what they mean for your kidney health.

It's important to note that eGFR naturally declines with age, even in healthy individuals. After age 40, kidney function typically decreases by about 1 mL/min/1.73m² per year. This means an eGFR of 70 in a 70-year-old might be less concerning than the same value in a 40-year-old. Your healthcare provider will consider your age when interpreting results.

Factors That Can Affect eGFR Accuracy

Several factors can influence eGFR calculations and potentially lead to inaccurate results. These include extreme muscle mass (very high in bodybuilders or very low in elderly or malnourished individuals), certain medications, recent high-protein meals, and pregnancy. Additionally, some medical conditions like liver disease or severe malnutrition can affect creatinine production, potentially skewing eGFR calculations.

The Connection Between Low eGFR and Chronic Kidney Disease

Low eGFR is not just a number—it's a direct reflection of your kidneys' declining ability to filter waste from your blood. When eGFR drops below 60 mL/min/1.73m², it means your kidneys are functioning at less than 60% of their normal capacity. This reduction in filtering efficiency leads to the accumulation of waste products in your blood, which can affect virtually every system in your body.

The relationship between low eGFR and CKD is so strong that eGFR is one of the primary diagnostic criteria for the condition. However, a single low reading doesn't automatically mean you have CKD. The diagnosis requires persistent low eGFR (below 60) for at least three months, or evidence of kidney damage through other tests like urine protein measurements, even if eGFR is above 60.

What makes low eGFR particularly concerning is that it often indicates irreversible kidney damage. Unlike acute kidney injury, which can sometimes be reversed with prompt treatment, CKD involves permanent scarring of kidney tissue. This is why early detection through regular testing is crucial—catching kidney dysfunction when eGFR is only mildly reduced provides the best opportunity to slow or halt disease progression.

Other Indicators of Kidney Disease

While eGFR is a crucial marker, healthcare providers don't rely on it alone to diagnose CKD. Other important tests include urine albumin-to-creatinine ratio (ACR), which detects protein leakage in urine, blood urea nitrogen (BUN) levels, and imaging studies. The presence of protein in urine (proteinuria) along with low eGFR strongly suggests kidney disease and indicates a higher risk of progression.

Common Causes of Low eGFR

Understanding what leads to low eGFR can help you identify risk factors and take preventive measures. The two leading causes of CKD in developed countries are diabetes and high blood pressure, accounting for about two-thirds of all cases. In diabetes, persistently high blood sugar damages the delicate filtering units in your kidneys over time. Similarly, uncontrolled high blood pressure puts excessive force on kidney blood vessels, causing them to narrow, weaken, or harden.

Other significant causes of low eGFR include polycystic kidney disease (a genetic condition causing cysts to form in the kidneys), glomerulonephritis (inflammation of the kidney's filtering units), and autoimmune diseases like lupus. Certain medications, particularly long-term use of NSAIDs (like ibuprofen), some antibiotics, and contrast dyes used in imaging procedures, can also damage kidneys and lower eGFR.

Lifestyle factors play a substantial role as well. Smoking constricts blood vessels and accelerates kidney function decline. Obesity increases the risk of diabetes and hypertension while directly stressing the kidneys. A diet high in processed foods, excessive salt, and inadequate hydration can also contribute to kidney dysfunction over time.

Risk Factors You Can't Control

Some risk factors for low eGFR are beyond your control but important to recognize. These include family history of kidney disease, age over 60, ethnicity (African Americans, Hispanics, and Native Americans have higher CKD risk), and being born with low birth weight or having a history of acute kidney injury. If you have these risk factors, regular monitoring becomes even more critical.

Upload your blood test results to track your progress

Seamlessly upload 3rd party biomarker & blood tests to track your whole health in 1 dashboard. Understand what each blood test means and how it fits into the bigger picture of your body and health.

Get diet and lifestyle recommendations based on your blood results, health profile and health goals. You'll also receive a custom supplement recommendation for the precise nutrients your body craves.

Upload Past Blood Test Results

Click or drag file to upload

Once you upload your report, we'll extract the results for your review. Works with top labs including Quest Diagnostics, LabCorp, BioReference, EverlyWell, LetsGetChecked and hundreds of other labs.

Symptoms Associated with Low eGFR

One of the most challenging aspects of chronic kidney disease is that symptoms often don't appear until kidney function has significantly declined. Many people with stage 1-3 CKD (eGFR above 30) experience no symptoms at all, which is why regular testing is so important for early detection.

As eGFR drops below 30-45 mL/min/1.73m² (stages 3b-4), symptoms may begin to emerge. These can include persistent fatigue and weakness due to anemia (kidneys produce less erythropoietin, a hormone that stimulates red blood cell production), swelling in the feet, ankles, or hands from fluid retention, and changes in urination patterns—either increased frequency, especially at night, or decreased urine output.

When eGFR falls below 15-30 mL/min/1.73m² (stages 4-5), symptoms become more pronounced and may include severe fatigue, nausea and vomiting, loss of appetite, metallic taste in the mouth, persistent itching, muscle cramps, shortness of breath, difficulty concentrating or confusion, and sleep problems. At this stage, patients typically need to prepare for dialysis or kidney transplantation.

Testing and Monitoring Your eGFR

Regular eGFR testing is a cornerstone of kidney health monitoring, especially if you have risk factors for CKD. The test itself is simple—it requires only a basic blood draw to measure creatinine levels. From this single measurement, combined with your age, sex, and race, laboratories calculate your eGFR using validated equations like the CKD-EPI formula.

For most adults, annual eGFR testing is sufficient as part of routine health screening. However, if you have diabetes, hypertension, or other CKD risk factors, your healthcare provider may recommend testing every 3-6 months. If you've already been diagnosed with CKD, monitoring frequency increases based on your stage—those with stage 3 CKD might test every 3-6 months, while stage 4 requires testing every 1-3 months.

Home testing options have made it easier than ever to monitor your kidney health regularly. Comprehensive at-home blood testing programs can include eGFR along with other important markers like BUN and creatinine, allowing you to track trends over time and catch changes early. This proactive approach to monitoring can help you and your healthcare provider make timely adjustments to protect your kidney function.

A single eGFR reading provides a snapshot, but tracking changes over time offers more valuable insights. A decline of more than 5 mL/min/1.73m² per year is considered rapid progression and warrants immediate medical attention. Conversely, stable eGFR over months or years, even if below normal, suggests well-controlled kidney disease. Your healthcare provider will look at these trends alongside other factors to assess your kidney health trajectory.

Treatment Options for Low eGFR

While chronic kidney disease cannot be cured, numerous treatments can slow its progression and manage complications. The approach depends on your eGFR level, the underlying cause, and the presence of other health conditions. Early-stage CKD (stages 1-3) focuses primarily on addressing the root causes and preventing further damage.

Blood pressure control is paramount, with ACE inhibitors or ARBs often prescribed as they provide kidney protection beyond their blood pressure-lowering effects. For those with diabetes, maintaining optimal blood sugar control through medication, diet, and lifestyle changes is essential. Target HbA1c levels below 7% can significantly slow kidney function decline.

As CKD progresses (stages 4-5), treatment expands to manage complications. This may include medications for anemia (erythropoiesis-stimulating agents or iron supplements), phosphate binders to prevent bone disease, vitamin D supplements, and careful management of potassium and fluid intake. When eGFR drops below 15, preparation for renal replacement therapy—either dialysis or kidney transplantation—becomes necessary.

Emerging Therapies

Recent advances in CKD treatment offer new hope. SGLT2 inhibitors, originally developed for diabetes, have shown remarkable kidney-protective effects even in non-diabetic CKD patients. Newer medications targeting inflammation and fibrosis pathways are in clinical trials. Additionally, artificial kidney devices and xenotransplantation research may revolutionize treatment options in the coming years.

Lifestyle Changes to Protect Your Kidneys

Your daily choices significantly impact kidney health and can help maintain or even improve eGFR. Diet modifications are particularly powerful—adopting a kidney-friendly diet low in sodium (less than 2,300 mg daily), moderating protein intake based on your CKD stage, and limiting phosphorus and potassium if advised by your healthcare provider can reduce kidney workload.

Regular physical activity improves blood pressure, blood sugar control, and overall cardiovascular health—all beneficial for kidney function. Aim for at least 150 minutes of moderate-intensity exercise weekly. Weight management is equally important, as obesity strains kidneys and increases CKD risk factors. Even modest weight loss can improve eGFR and slow disease progression.

Other crucial lifestyle factors include staying well-hydrated (unless fluid-restricted), quitting smoking (which accelerates kidney function decline), limiting alcohol consumption, managing stress through techniques like meditation or yoga, and avoiding nephrotoxic substances like NSAIDs when possible. Regular monitoring through comprehensive health testing helps you track how these changes impact your kidney function over time.

Taking Action for Your Kidney Health

Low eGFR is indeed a strong indicator of chronic kidney disease, but it's not a death sentence. With early detection, appropriate medical care, and lifestyle modifications, many people with CKD maintain good quality of life for years or even decades. The key is catching kidney dysfunction early, when interventions are most effective at slowing or halting progression.

If you have risk factors for kidney disease—diabetes, hypertension, family history, or are over 60—don't wait for symptoms to appear. Regular eGFR testing, along with other kidney function markers, provides the information you need to protect your kidney health proactively. Remember, your kidneys work hard for you every day; taking steps to monitor and maintain their function is one of the best investments you can make in your long-term health.

References

  1. Levey, A. S., Stevens, L. A., Schmid, C. H., et al. (2009). A new equation to estimate glomerular filtration rate. Annals of Internal Medicine, 150(9), 604-612.[PubMed][DOI]
  2. KDIGO CKD Work Group. (2024). KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney International, 105(4S), S117-S314.[DOI]
  3. Chen, T. K., Knicely, D. H., & Grams, M. E. (2019). Chronic Kidney Disease Diagnosis and Management: A Review. JAMA, 322(13), 1294-1304.[PubMed][DOI]
  4. Heerspink, H. J. L., Stefánsson, B. V., Correa-Rotter, R., et al. (2020). Dapagliflozin in Patients with Chronic Kidney Disease. New England Journal of Medicine, 383(15), 1436-1446.[PubMed][DOI]
  5. Grams, M. E., & Coresh, J. (2023). Predicting Risk of Chronic Kidney Disease: The CKD Prognosis Consortium. Current Opinion in Nephrology and Hypertension, 32(3), 238-245.[PubMed]
  6. Webster, A. C., Nagler, E. V., Morton, R. L., & Masson, P. (2017). Chronic Kidney Disease. The Lancet, 389(10075), 1238-1252.[PubMed][DOI]

Was this article helpful?

Frequently Asked Questions

How can I test my eGFR at home?

You can test your eGFR at home with SiPhox Health's Heart & Metabolic Program, which includes eGFR testing along with other kidney function markers like BUN and creatinine. This CLIA-certified program provides lab-quality results from the comfort of your home.

What is the normal range for eGFR?

Normal eGFR is typically above 90 mL/min/1.73m², though values between 60-89 may be acceptable depending on age. Values below 60 for three months or more indicate chronic kidney disease. eGFR naturally declines with age, decreasing by about 1 mL/min/1.73m² per year after age 40.

Can low eGFR be reversed?

While chronic kidney disease causing persistently low eGFR cannot be cured, early intervention can slow or halt progression. Acute causes of low eGFR may be reversible with treatment. Managing blood pressure, blood sugar, and following a kidney-friendly lifestyle can help preserve remaining kidney function.

How often should I test my eGFR if I have risk factors?

If you have diabetes, hypertension, or other CKD risk factors, testing every 3-6 months is recommended. Those already diagnosed with CKD may need more frequent monitoring—every 3-6 months for stage 3, and every 1-3 months for stage 4.

What symptoms indicate my eGFR might be low?

Early-stage kidney disease often has no symptoms. As eGFR drops below 45, you may experience fatigue, swelling in feet or ankles, changes in urination, and poor appetite. Below 30, symptoms include severe fatigue, nausea, itching, muscle cramps, and difficulty concentrating.

This article is licensed under CC BY 4.0. You are free to share and adapt this material with attribution.

Ask Questions About Any Health Topic

Chat with Sai, our AI health assistant, for personalized insights.

Click or drag file to upload blood test results

Backed By Leading Experts in Health Optimization

Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details